In a monumental selection, LIFE AI has been selected to participate in Cohort 1, the first-ever FastTrack AI accelerator. The program, supported by GenAI Fund and accelerated by NVIDIA, is designed to fast-track the most promising AI startups for enterprise adoption, scalable impact, and investment readiness.
By joining the number one enterprise startup accelerator in the ASEAN region, LIFE AI will be able to significantly advance AI in a shorter period of time to empower the healthcare industry, allowing the company to prove:
Access to GPU resources, technical support from NVIDIA experts, and other cloud provider resources
Selected enterprise PoC opportunities through GenAI Open Invitation Network
Investment evaluation and establishment opportunities from GenAI Fund and its partners
But before being selected from over 300 applicants as one of six startups to participate in Cohort 1, LIFE AI made a splash as an intelligent layer for human health, reducing barriers to healthcare product development while simultaneously making the process 10x faster and 10x cheaper.
Founded by former Google engineering leader Dr. Tuan Cao and other engineers and scientists from Cornell University, UC Berkeley, and UCSF, the company already provides precision medicine services to more than 100,000 paying users in seven countries, including the United States, South Korea, Hong Kong, Singapore, Indonesia, Thailand, and Vietnam.
LIFE AI has more than 100 corporate and institutional partners, including research collaborations with scientists at Stanford University, Cornell University, and UCSF, and a vast network of hospitals across Asia. The company conducted Southeast Asia’s largest autism genetic study at a cost of $10,000 instead of an estimated $1 million or more, and helped Southeast Asia’s largest pharmaceutical company, Carve Pharma, launch a personalized stroke prevention product in six weeks instead of the originally planned 24 months.
This dramatic acceleration (reducing the typical 24-month development cycle to just six weeks), combined with the establishment of Southeast Asia’s largest genome sequencing center, serves as a blueprint for LIFE AI’s platform capabilities and capabilities, making it a pivotal proof point for the company’s value proposition.
LIFE AI brings its blossoming revenue model and platform offering to the FastTrack AI Accelerator, moving from a traditional model to an AI-first “Model-as-a-Service” strategy focused on real products, real customers, and real revenue.
Being selected for such a prestigious program is an exciting milestone in LIFE AI’s journey to scale AI innovation and create meaningful impact across Southeast Asia. Over the next 12 weeks, the FastTrack AI Accelerator provides up to $1 million in compute power, technical support from NVIDIA, and practical guidance to accelerate impactful results.
LIFE AI is proud to join this pioneering first cohort that will shape the future of applied AI with innovation, speed, and scale. This journey will help us continue our excellence in providing end-to-end solutions for healthcare product development, natively integrating blockchain to ensure ownership, privacy, and transparency.
About LIFE AI
LIFE AI is a Singapore-based company that operates a foundational AI platform that enables companies to bring precision medicine, drug discovery and other life science products from idea to market faster and at lower cost. The company is pioneering the future of health by building a layer of human health intelligence. This is a new foundational infrastructure where real humans, AI computing, and impact-driven models are integrated into an advanced co-creation ecosystem.
Website | X.com | Telegram
